HSBC Holdings’s Kronos Bio KRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-38,368
Closed -$32.6K 3133
2025
Q1
$32.6K Hold
38,368
﹤0.01% 2941
2024
Q4
$36.3K Hold
38,368
﹤0.01% 3019
2024
Q3
$38K Hold
38,368
﹤0.01% 2906
2024
Q2
$48K Hold
38,368
﹤0.01% 2823
2024
Q1
$49.9K Hold
38,368
﹤0.01% 2938
2023
Q4
$45.3K Hold
38,368
﹤0.01% 2656
2023
Q3
$48.3K Hold
38,368
﹤0.01% 2631
2023
Q2
$65.8K Hold
38,368
﹤0.01% 2478
2023
Q1
$58.3K Buy
38,368
+24,948
+186% +$47.8K ﹤0.01% 2557
2022
Q4
$20.1K Hold
13,420
﹤0.01% 3014
2022
Q3
$46K Hold
13,420
﹤0.01% 2827
2022
Q2
$50K Buy
+13,420
New +$60.8K ﹤0.01% 3136

HSBC Holdings's KRON Position: Q2 2025 in Review

HSBC Holdings sold out of Kronos Bio (KRON) in Q2 2025, closing a stake of 38,368 shares — an estimated $32.6K sold.

HSBC Holdings first reported a position in KRON in Q2 2022 and held it in 12 quarters. The position peaked at $65.8K in Q2 2023. 0 funds tracked by Wall St. Rank hold KRON as of Q2 2025.

  • HSBC Holdings reported no remaining Kronos Bio position as of Q2 2025 after selling out during the quarter.
  • HSBC Holdings sold 38,368 Kronos Bio shares in Q2 2025, an estimated $32.6K.
  • HSBC Holdings first reported a position in Kronos Bio in Q2 2022 and held it in 12 quarters.
  • HSBC Holdings's Kronos Bio position peaked at $65.8K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2025.

Based on HSBC Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.